Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 716

1.

Treatment Options for Gout.

Engel B, Just J, Bleckwenn M, Weckbecker K.

Dtsch Arztebl Int. 2017 Mar 31;114(13):215-222. doi: 10.3238/arztebl.2017.0215.

2.

Current management of gout: practical messages from EULAR 2016 guidelines.

Nuki G, Doherty M, Richette P.

Pol Arch Intern Med. 2017 Apr 21. doi: 10.20452/pamw.4001. [Epub ahead of print]

3.

Lesinurad: A Review in Hyperuricaemia of Gout.

Deeks ED.

Drugs Aging. 2017 Apr 19. doi: 10.1007/s40266-017-0461-y. [Epub ahead of print]

PMID:
28425024
4.

Development of Nephrolithiasis in Asymptomatic Hyperuricemia: A Cohort Study.

Kim S, Chang Y, Yun KE, Jung HS, Lee SJ, Shin H, Ryu S.

Am J Kidney Dis. 2017 Apr 12. pii: S0272-6386(17)30548-6. doi: 10.1053/j.ajkd.2017.01.053. [Epub ahead of print]

PMID:
28410765
5.

Performance of the 2015 American College of Rheumatology/European League Against Rheumatism gout classification criteria in Thai patients.

Louthrenoo W, Jatuworapruk K, Lhakum P, Pattamapaspong N.

Rheumatol Int. 2017 May;37(5):705-711. doi: 10.1007/s00296-017-3708-3. Epub 2017 Mar 27.

PMID:
28349197
6.

Acute Gout Following Dermofasciectomy in a Patient With Dupuytren Disease.

Cochrane E, Harper R.

J Hand Surg Am. 2017 Jan;42(1):e49-e50. doi: 10.1016/j.jhsa.2016.09.016. Epub 2016 Oct 27.

PMID:
28341038
7.

Dinuclear cyclam complex as a non-cytotoxic, anti-hyperurecemic lead: In vitro to in vivo studies.

Zafar H, Hamdi N, Lachkar M, El Bali B, Khan A, Choudhary MI.

Med Chem. 2017 Mar 8. doi: 10.2174/1573406413666170309095104. [Epub ahead of print]

PMID:
28290251
8.

Value of ultrasonography in the diagnosis of gout in patients presenting with acute arthritis.

Pattamapaspong N, Vuthiwong W, Kanthawang T, Louthrenoo W.

Skeletal Radiol. 2017 Jun;46(6):759-767. doi: 10.1007/s00256-017-2611-z. Epub 2017 Mar 8.

PMID:
28275814
9.

[Association of asymptomatic hyperuricemia with mortality in patients undergoing elective percutaneous coronary intervention].

Liu XM, Dong JZ, Liu XH, Kang JP, Lü J, Zhang Y, Luo TY, Guan Y, Dai TY, Guo F, Bai R, Du X, Ma CS.

Zhonghua Yi Xue Za Zhi. 2017 Feb 21;97(7):508-511. doi: 10.3760/cma.j.issn.0376-2491.2017.07.007. Chinese.

PMID:
28260289
10.

Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition.

Zhao P, Chen KL, Zhang GL, Deng GR, Li J.

Evid Based Complement Alternat Med. 2017;2017:2103254. doi: 10.1155/2017/2103254. Epub 2017 Jan 5.

11.

Fabrication of nitrogen-doped carbon dots for screening the purine metabolic disorder in human fluids.

Gowthaman NSK, Sinduja B, Karthikeyan R, Rubini K, Abraham John S.

Biosens Bioelectron. 2017 Aug 15;94:30-38. doi: 10.1016/j.bios.2017.02.034. Epub 2017 Feb 24.

PMID:
28249204
12.

Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data.

Essex MN, Hopps M, Bienen EJ, Udall M, Mardekian J, Makinson GT.

J Clin Rheumatol. 2017 Apr;23(3):160-166. doi: 10.1097/RHU.0000000000000496.

PMID:
28248798
13.

Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 3: Treatment.

Schlee S, Bollheimer LC, Bertsch T, Sieber CC, Härle P.

Z Gerontol Geriatr. 2017 Feb 28. doi: 10.1007/s00391-017-1199-1. [Epub ahead of print] Review.

PMID:
28246893
14.

Is tea consumption associated with the serum uric acid level, hyperuricemia or the risk of gout? A systematic review and meta-analysis.

Zhang Y, Cui Y, Li XA, Li LJ, Xie X, Huang YZ, Deng YH, Zeng C, Lei GH.

BMC Musculoskelet Disord. 2017 Feb 28;18(1):95. doi: 10.1186/s12891-017-1456-x.

15.

Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 1: Epidemiology and pathophysiology.

Schlee S, Bollheimer LC, Bertsch T, Sieber CC, Härle P.

Z Gerontol Geriatr. 2017 Feb 23. doi: 10.1007/s00391-017-1197-3. [Epub ahead of print] Review.

PMID:
28233117
16.

Association of serum uric acid with subsequent arterial stiffness and renal function in normotensive subjects.

Nagano S, Takahashi M, Miyai N, Oka M, Utsumi M, Shiba M, Mure K, Takeshita T, Arita M.

Hypertens Res. 2017 Feb 16. doi: 10.1038/hr.2017.10. [Epub ahead of print]

PMID:
28202946
17.

Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review.

Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK.

J Rheumatol. 2017 Mar;44(3):388-396. doi: 10.3899/jrheum.160452. Epub 2017 Feb 1.

PMID:
28148699
18.

The unclosing premature mortality gap in gout: a general population-based study.

Fisher MC, Rai SK, Lu N, Zhang Y, Choi HK.

Ann Rheum Dis. 2017 Jan 25. pii: annrheumdis-2016-210588. doi: 10.1136/annrheumdis-2016-210588. [Epub ahead of print]

PMID:
28122760
19.

Diagnosis and Treatment of Gouty Tophi in the Patellar Tendon Using Ultrasound-Guided Needle Barbotage: A Case Presentation.

Colberg RE, Geffen RB.

PM R. 2017 Jan 16. pii: S1934-1482(17)30039-4. doi: 10.1016/j.pmrj.2016.12.013. [Epub ahead of print]

PMID:
28104531
20.

The safety of treatment options available for gout.

Schlesinger N.

Expert Opin Drug Saf. 2017 Apr;16(4):429-436. doi: 10.1080/14740338.2017.1284199. Epub 2017 Jan 30. Review.

PMID:
28095258

Supplemental Content

Loading ...
Support Center